Summary
COS-1 cells were transfected by electroporation with a cDNA for human acid β-galactosidase cloned in our laboratory and stable transformants expressing the enzyme activity were selected. The precursor form of the enzyme was secreted in large quantities into the culture medium. The fibroblasts from patients with GM1-gangliosidosis or Morquio B disease showed a remarkable increase of enzyme activity, up to the normal level, after culture in this medium for 2 days; the amount of uptake was essentially the same as that for the precursor form in human fibroblasts. After endocytosis, the precursor molecules were processed normally to the mature form and remained as stable as those produced by human fibroblasts. On the other hand, cells from galactosialidosis patients did not show any increase of enzyme activity in a similar experiment. It was concluded that the transformants are useful as the source of precursor proteins for the study of intracellular turnover of enzyme molecules in mutant cells.
Similar content being viewed by others
References
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the prinicple of protein-dye binding. Anal Biochem 72:248–254
Creek KE, Sly WS (1984) The role of the phosphomannosyl receptor in the transport of acid hydrolases to lysosomes. In: Dingle JT, Dean RT, Sly WS (eds) Lysosomes in biology and pathology, vol 7. Elsevier, Amsterdam, pp 63–82
D'Azzo A, Hoogeveen A, Reuser AJJ, Robinson D, Galjaard H (1982) Molecular defect in combined β-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci USA 79:4335–4339
Diggelen OP van, Schram AW, Sinnott ML, Smith PJ, Robinson D, Galjaard H (1981) Turnover of β-galactosidase in fibroblasts from patients with genetically different types of β-galactosidase deficiency. Biochem J 200:143–151
Galjart NJ, Gillemans N, Harris A, Horst GTJ van der, Verheijen FW, Galjaard H, D'Azzo A (1988) Expression of cDNA encoding the human “protective protein” associated with lysosomal β-galactosidase and neuraminidase: homology to yeast proteases. Cell 54:755–764
Harlander SK (1981) Transfection of Streptococcus lactis by electroporation. In: Ferretti JJ, Curtiss R (eds) Streptococcus genetics. American Society for Microbiology. Washington, DC, pp 229–233
Hasilik A, Neufeld EF (1980) Biosynthesis of lysosomal enzymes in fibroblasts. J Biol Chem 255:4937–4945
Hoogeveen AT, Verheijen FW, Galjaard H (1983) The relation between human lysosomal β-galactosidase and its protective protein. J Biol Chem 258:12143–12146
Hoogeveen AT, Graham-Kawashima H, D'Azzo A, Galjaard H (1984) Processing human β-galactosidase in GM1-gangliosidosis and Morquio B disease. J Biol Chem 259:1974–1977
Hoogeveen AT, Reuser AJJ, Kroos M, Galjaard H (1986) GM1Gangliosidosis: defective recognition site on β-galactosidase precursor. J Biol Chem 261:5702–5704
Horst GTJ van der, Kleijer WJ, Hoogeveen AT, Huijman JGM, Blom W, Diggelen OP van (1983) Morquio B syndrome: a primary defect in β-galactosidase. Am J Med Genet 16:261–275
Jalanko A, Kallio A, Ruohonen-Lehto M, Soderlund H, Ulmanen I (1988) An EBV-based mammalian cell expression vector for efficient expression of cloned coding sequences. Biochim Biophys Acta 949:206–212
Ko Y, Suzuki Y (1985) Experimental studies on enzyme replacement therapy of genetic β-galactosidase deficiency. II. Studies on β-galactosidase human tissues. Nippon Shonika Gakkai Zasshi 89:553–559
Kornfeld S (1986) Trafficking of lysosomal enzymes in normal and disease states. J Clin Invest 77:1–6
Morreau H, Galjart NJ, Gillemans N, Willemsen R, Horst GTJ van der, D'Azzo A (1989) Alternative splicing of β-galactosidase mRNA generates the classic lysosomal enzyme and a β-galactosidase-related protein. J Biol Chem 264:20655–20663
Motegi Y, Fujinaga T, Tamura H, Kuroume T, Omura K, Nanba E, Suzuki Y (1987) Severe infantile galactosialidosis: a case report. Nippon Shonika Gakkai Zasshi 91:1459–1464
Nanba E, Tsuji A, Omura K, Suzuki Y (1987) Galactosialidosis: direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts. Biochem Biophys Res Commun 144:138–142
Nanba E, Tsuji A, Omura K, Suzuki Y (1988a) GM1-gangliosidosis: abnormalities in biosynthesis and early processing of β-galactosidase in fibroblasts. Biochem Biophys Res Commun 152:794–800
Nanba E, Tsuji A, Omura K, Suzuki Y (1988b) Galactosialidosis: molecular heterogeneity in biosynthesis and processing of protective protein for β-galactosidase. Hum Genet 88:329–332
Nolan CM, Sly WS (1989) I-cell disease and pseudo-Hurler polydystrophy: disorder of lysosomal enzyme phosphorylation and localization. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGrawHill, New York, pp 1589–1601
O'Brien JS (1989) β-Galactosidase deficiency (GM1-gangliosidosis, galactosialidosis, and Morquio syndrome type B); ganglioside sialidase deficiency (mucolipidosis IV). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp1797–1806
Okada S, O'Brien JS (1968) Generalized gangliosidosis: β-galactosidase deficiency. Science 160:1002–1004
Oshima A, Kyle JW, Miller RD, Hoffmann JW, Powell PP, Grubb JH, Sly WS, Tropak KS, Guise KS, Gravel RA (1987) Cloning, sequencing, and expression of cDNA for human β-glucuronidase. Proc Natl Acad Sci USA 84:685–689
Oshima A, Tsuji A, Nagao Y, Sakuraba H, Suzuki Y (1988) Cloning, sequencing, and expression of cDNA for human β-galactosidase. Biochem Biophys Res Commun 157:238–244
Proia RL, D'Azzo A, Neufeld EF (1984) Association of α and β-subunits during the biosynthesis of β-hexosaminidase in cultured human fibroblasts. J Biol Chem 259:3350–3354
Sakuraba H, Aoyagi T, Suzuki Y (1982) Galactosialidosis (β-galactosidase-neuraminidase deficiency): a possible role of serinethiol proteases in the degradation of β-galactosidase molecules. Clin Chim Acta 125:275–282
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oshima, A., Itoh, K., Nagao, Y. et al. β-Galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells. Hum Genet 85, 505–508 (1990). https://doi.org/10.1007/BF00194225
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00194225